Work

Research progress on the treatment of infertility resulting from a thin endometrium using menstrual blood–derived mesenchymal stem cells: from regenerative potential to challenges in clinical translation

Year: 2026
Type: article
Abstract: Background A thin endometrium (TE) importantly influences female fertility and the outcomes of assisted reproductive methods. Its pathogenesis involves multiple processes, including basal layer injury, impaired angiogenesis, stromal fibrosis, and reduced regenerative capacity. Menstrual blood–derived mesenchymal stem cells (MenSCs) have attracted increasing attention in endometrial regenerative medicine because of their proliferative and paracrine properties. However, evidence regarding their use in TE remains fragmented, with relatively limited data from TE-specific models and clinical studies. Objective This review summarizes the biological characteristics, potential therapeutic mechanisms, experimental and clinical evidence, and translational challenges of MenSCs for TE treatment. Methods PubMed was searched for studies published through June 2026 on MenSCs in TE and related endometrial disorders. Basic research, animal studies, clinical investigations, and relevant reviews were included. When direct evidence from TE studies was unavailable, mechanistic findings from related models, including intrauterine adhesions (IUAs), Asherman syndrome (AS), endometrial injury, and fibrosis, were evaluated, with explicit differentiation between direct and indirect evidence. Results Current evidence suggests that MenSCs may promote endometrial repair by enhancing cell proliferation and angiogenesis, attenuating fibrosis, modulating the immune microenvironment, and exerting paracrine and extracellular vesicle-mediated effects. Animal studies indicate potential improvements in endometrial thickness and the regeneration of glands and blood vessels, with some studies reporting improved reproductive outcomes. Preliminary clinical studies also suggest therapeutic potential. However, available studies involve small sample sizes, and much of the mechanistic evidence is derived from intrauterine adhesion, AS, or other related models. Direct experimental and high-quality clinical evidence specific to TE remains insufficient. Conclusion MenSCs represent a promising potential strategy for endometrial regeneration, but robust evidence supporting their efficacy and mechanisms in TE is lacking. Future studies should employ TE-relevant disease models, standardized clinical trials, and rigorous protocols for cell preparation, administration, and long-term safety assessment to facilitate clinical translation.
Language: English
Subfield: Cell Biology
Open Access status: gold
Estimated APC paid: $3,801
OpenAlex ID: W7226033423
FWCI:
Cites: 98
Cited by:
Related to: 10